Ms. Iurkova is experienced in brand promotion, business development, marketing communications, and public relations. Prior to becoming Business Development Director for BIOMEDICA CRO, Iryna worked at Deloitte, Bayer, and AB InBev. She has a Master’s Degree in International Business Management. For the last seven years, Iryna has successfully worked in the field of human biospecimens, managing numerous complex projects.
Human biospecimens research showed the link between thirdhand smoking and skin disorders
Scientists found that acute exposure of the s...
The work on early cancer detection in blood samples via cooperation with human biospecimens providers
The research group discovered a new approach ...
Breast cancer research and how BIOMEDICA CRO participates in preclinical studies
The results of research on tumor tissues and...
Aspirin in cancer treatment – from supplying biospecimens to discovering new therapy types
Acetylsalicylic acid (aspirin) in cancer trea...
New COVID-19 vaccine development and how BIOMEDICA CRO helps to move science forward
The new vaccine for SARS-CoV-2 is to target b...
Multiple Myeloma research and the role of human biospecimens providers
Multiple Myeloma therapy options - the review...
Blood specimens collection by BIOMEDICA CRO for further cancer monitoring and research
Liquid biopsy and metastatic Prostate cancer ...
Saliva samples analysis for objective diagnostic of people suffering from Post-Traumatic Stress Disorder
Using saliva specimens for PTSD diagnostic – ...
